tiprankstipranks
Crinetics Pharmaceuticals (CRNX)
NASDAQ:CRNX
US Market
CRNX
Crinetics Pharmaceuticals
RESEARCH TOOLSreports
Want to see CRNX full AI Analyst Report?

Crinetics Pharmaceuticals (CRNX) Income Statement

764 Followers

Crinetics Pharmaceuticals Income Statement

Last quarter (Q4 2025), Crinetics Pharmaceuticals's total revenue was $3.88M, an increase of Infinity% from the same quarter last year. In Q4, Crinetics Pharmaceuticals's net income was $-122.81M. See Crinetics Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 7.70M$ 1.04M$ 4.01M$ 4.74M$ 1.08M
Gross Profit
$ 2.73M$ 1.04M$ 4.01M$ 4.74M$ 1.08M
Operating Expenses
$ 519.50M$ 339.89M$ 226.62M$ 172.62M$ 108.78M
Depreciation and Amortization
$ 3.89M$ 2.79M$ 1.10M$ 983.00K$ 922.00K
EBITDA
$ -461.25M$ -336.07M$ -221.51M$ -166.90M$ -106.78M
Operating Income
$ -516.77M$ -338.85M$ -222.61M$ -167.88M$ -107.70M
Other Income/Expenses
$ 51.63M$ 40.45M$ 8.08M$ 3.96M$ 61.00K
Pretax Income
$ -465.14M$ -298.41M$ -214.53M$ -163.92M$ -107.64M
Net Income
$ -465.32M$ -298.41M$ -214.53M$ -163.92M$ -107.64M
Per Share Metrics
Basic EPS
$ -4.95$ -3.69$ -3.69$ -3.15$ -2.80
Diluted EPS
$ -4.95$ -3.69$ -3.69$ -3.15$ -2.80
Weighted Average Shares Outstanding
 94.06M 80.78M 58.07M 51.98M 38.44M
Weighted Average Shares Outstanding (Diluted)
 94.06M 80.78M 58.07M 51.98M 38.44M
Currency in USD

Crinetics Pharmaceuticals Earnings and Revenue History